Dr. Travis Edward Grotz, MD

Dr. Grotz practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Grotz's NPI, 1245496934, was assigned on August 1, 2008. Dr. Grotz graduated from Creighton University School of Medicine - Omaha in 2008. Dr. Grotz holds Minnesota license 51925.

Dr. Grotz's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Grotz's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Grotz to 1 more hospice, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grotz practices, 2 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Grotz's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Grotz is board certified in complex general surgical oncology by the American Board of Surgery. Dmand AI has Dr. Grotz's licenses on file in 2 states: Minnesota and Texas.

Dmand AI lists abdominal adhesion surgery, appendectomy, colon removal, esophagus, stomach, or upper small intestine surgery, gastrointestinal obstruction and groin hernia surgery among the conditions Dr. Grotz treats.

CMS data shows 75 Medicare services from Dr. Grotz across 3 procedure codes in 2024, for 74 Medicare patients. Medicare paid $21,929 for them.

CMS counts 74 Medicare patients who saw Dr. Grotz in 2024. The largest group is 65 to 74, with 43 patients. 65% of them have high blood pressure, and 62% have high cholesterol. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grotz's median patient age at 66, with 36% women.

In 2024, Dr. Grotz wrote 62 Medicare Part D claims for 24 patients. 98% of them were for generic drugs. CMS names the drug for 58 of them, across 3 drugs with 11 or more claims each, at $158 in total drug cost. In 2023, CMS named 53 claims across 3 drugs.

Dr. Grotz accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Hernia repair - groin (open): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 103 papers to Dr. Grotz, published from 2010 to 2025. 2020 was the busiest year, with 11. The most frequent topics are Cytoreduction Surgical Procedures, Peritoneal Neoplasms and Hyperthermia, Induced. Dr. Grotz has published most often in Ann Surg Oncol. Dr. Grotz's most frequent co-authors are Keith Francis Fournier, MD, Sean Patrick Dineen, MD and Laura A. Lambert, MD.

Dmand AI links Dr. Grotz to 1 clinical trial. 1 is still active or recruiting.

CMS Open Payments shows 11 general payments to Dr. Grotz from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 62% of the total. Taiho Oncology, Inc. paid the most, $162.

Dmand AI lists 11 awards for Dr. Grotz, most recently Balfour Award in 2013. Dr. Grotz serves on Debbies Dream Foundation, American Board of Surgery and Hope for Stomach Cancer.

Dr. Grotz graduated from Creighton University School of Medicine - Omaha in 2008. Dr. Grotz is a member of ACS, ASCO, International Gastric Cancer Congress (IGCC), Peritoneal Surface Oncology Group International (PSOGI) and SSO.

Dr. Grotz is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.